CIRV2 is a Phase IV randomized, open-label, trial of FDA-approved COVID-19 and/or influenza vaccines (no more than minimal risk) with longitudinal follow-up. I…

COVID -19COVID - 19COVID 19+5 more

~Estimated

~$25 – $1,000

Actual pay is set by the research site.

Henry M. Jackson Foundation for the Advancement of Military MedicineNCT07287137

Phase 1

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

Background: Influenza (flu) is a virus that can infect humans and animals. In humans, the flu can cause mild symptoms such as fever, cough, sore throat, runny…

Influenza InfectionInfectionsRespiratory Virus Infections+4 more

~Estimated

~$500 – $6,750

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT07215871